Collegium Pharmaceutical, Inc. (COLL)
22.75
-0.17
(-0.74%)
USD |
NASDAQ |
Sep 11, 16:00
22.76
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Market Cap : 739.34M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 739.34M |
| September 10, 2026 | 744.86M |
| September 09, 2026 | 759.16M |
| September 08, 2026 | 759.49M |
| September 04, 2026 | 764.68M |
| September 03, 2026 | 770.21M |
| September 02, 2026 | 789.71M |
| September 01, 2026 | 779.96M |
| August 31, 2026 | 799.78M |
| August 28, 2026 | 823.83M |
| August 27, 2026 | 859.26M |
| August 26, 2026 | 894.03M |
| August 25, 2026 | 892.73M |
| August 24, 2026 | 888.83M |
| August 21, 2026 | 881.03M |
| August 20, 2026 | 895.00M |
| August 19, 2026 | 934.00M |
| August 18, 2026 | 926.20M |
| August 17, 2026 | 912.23M |
| August 14, 2026 | 917.43M |
| August 13, 2026 | 914.83M |
| August 12, 2026 | 835.21M |
| August 11, 2026 | 844.31M |
| August 10, 2026 | 883.95M |
| August 07, 2026 | 957.72M |
| Date | Value |
|---|---|
| August 06, 2026 | 946.03M |
| August 05, 2026 | 1.161B |
| August 04, 2026 | 1.161B |
| August 03, 2026 | 1.153B |
| July 31, 2026 | 1.147B |
| July 30, 2026 | 1.166B |
| July 29, 2026 | 1.176B |
| July 28, 2026 | 1.163B |
| July 27, 2026 | 1.151B |
| July 24, 2026 | 1.141B |
| July 23, 2026 | 1.153B |
| July 22, 2026 | 1.125B |
| July 21, 2026 | 1.162B |
| July 20, 2026 | 1.152B |
| July 17, 2026 | 1.169B |
| July 16, 2026 | 1.175B |
| July 15, 2026 | 1.190B |
| July 14, 2026 | 1.135B |
| July 13, 2026 | 1.128B |
| July 10, 2026 | 1.142B |
| July 09, 2026 | 1.160B |
| July 08, 2026 | 1.161B |
| July 07, 2026 | 1.181B |
| July 06, 2026 | 1.214B |
| July 02, 2026 | 1.200B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.501B |
| Zevra Therapeutics, Inc. | 712.70M |
| Supernus Pharmaceuticals, Inc. | 2.422B |
| Indivior Pharmaceuticals, Inc. | 4.070B |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 8.988B |
Market Cap Related Metrics
| PE Ratio | 18.43 |
| PS Ratio | 1.07 |
| PEG Ratio | 0.9624 |
| Price to Book Value | 2.370 |
| Price to Free Cash Flow | 2.634 |
| Price | 22.75 |
| Earnings Yield | 5.43% |
| PEGY Ratio | 0.9624 |
| Operating PE Ratio | 5.318 |
| Normalized PE Ratio | 14.10 |